Luminex Corporation Recalls Blood Culture Assays Due to Diagnostic Risk
Luminex Corporation is updating instructions for its blood culture assay to address risks of incorrect or delayed diagnoses.
Luminex Corporation has issued a recall for its LIAISON PLEX Gram-Negative Blood Culture Assay, Catalog No. 20-005-303.
The Instructions for Use needed to be updated to explicitly recommend repeat testing whenever a positive family-level only result is obtained. The issue may contribute to an incorrect or delayed diagnosis of a bloodstream infection.
The recall involves 30,168 test cartridges, or 2,514 kits, distributed nationwide across the United States. The recall is classified as Class II by the U.S. Food and Drug Administration (FDA).
What to do
- Stop using the affected blood culture assays immediately.
- Review updated guidance regarding repeat testing for positive family-level only results.
- Contact Luminex Corporation or the FDA for additional information.
At a glance
| Agency | U.S. Food and Drug Administration (FDA) |
|---|---|
| Recall number | Z-0359-2027 |
| Date | 2026-11-11 |
| Company | Luminex Corporation, Northbrook, IL |
| Severity | Class II |
| Quantity | 30,168 test cartridges (2,514 Kits) |
| Where sold | US distribution nationwide. No OUS distribution. |
| Lot codes / identifiers | All lots UDI-DI pending |
Source: official FDA notice. This summary was written by 365 News from the official notice. Details can change; check the notice before acting.